Skip to Content

Label Changes for:

Paxil (Paroxetine Hydrochloride) Tablets and Oral Suspension

December 2012

Changes have been made to the CONTRAINDICATIONS, WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)


December 2012


(Serotonin Toxicity associated with co-administration with Linezolid and Methylene Blue)